These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Possible paliperidone-induced neuroleptic malignant syndrome: a case report. Özdemir A; Aksoy-Poyraz C; Kılıç-Yener E J Neuropsychiatry Clin Neurosci; 2012; 24(3):E22-3. PubMed ID: 23037666 [No Abstract] [Full Text] [Related]
3. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. Teng PR; Lane HY J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327 [No Abstract] [Full Text] [Related]
13. Possible paliperidone-related pons infarction. Chang CC; Wang WF; Lai TJ J Neuropsychiatry Clin Neurosci; 2014; 26(1):E15-6. PubMed ID: 24515693 [No Abstract] [Full Text] [Related]
14. Atypical Neuroleptic Malignant Syndrome Associated With Paliperidone Long-Acting Injection: A Case Report. Langley-DeGroot M; Joshi Y; Lehman D; Rao S J Clin Psychopharmacol; 2016 Jun; 36(3):277-9. PubMed ID: 27043124 [No Abstract] [Full Text] [Related]
15. Antipsychotic induced catatonia: a case of probable dementia with Lewy bodies. Xiong GL; Palomino A; Kahn DR; Bourgeois JA J Neuropsychiatry Clin Neurosci; 2009; 21(4):472-3. PubMed ID: 19996262 [No Abstract] [Full Text] [Related]
16. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient. Hou YC; Lai CH J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786 [No Abstract] [Full Text] [Related]
18. Manic symptoms during a switch from risperidone to paliperidone: a case report. Yang FW; Liang CS J Neuropsychiatry Clin Neurosci; 2011; 23(3):E29. PubMed ID: 21948917 [No Abstract] [Full Text] [Related]